Energy And Commerce Committee Inquires Into FDA Contracting Conflicts
This article was originally published in The Gray Sheet
Executive Summary
The new Democratic-controlled House Energy and Commerce Committee initiated its first public inquiry into FDA Jan. 22, seeking documents on the oversight of conflicts of interest in the agency's contract awarding practices
You may also be interested in...
Retiring Rep. Dingell’s Health Policy Legacy Includes Fierce Oversight Of Device Center
A powerful former Chairman of the House Energy and Commerce Committee, Dingell has been not only a major player in the health care reform fight, but also a vigorous prober of FDA, launching investigations with lasting effects on the device center. The longest-serving member of the House announced his plans to retire at the end of this congressional term.
Retiring Rep. Dingell’s Health Policy Legacy Included Fierce Oversight Of Device Center
A powerful former Chairman of the House Energy and Commerce Committee, Dingell has not been only a major player in the health care reform fight, but also a vigorous prober of FDA, launching investigations with lasting effects on the device center. The longest-serving member of the House announced his plans to retire at the end of this congressional term.
Ex-FDA Commissioner Pleads Guilty To Conflicts, False Statements
Former FDA Commissioner Lester Crawford pleaded guilty in D.C. federal court Oct. 17 to owning company stocks that caused conflicts of interest and to making false statements about those stock holdings during his tenure at the agency